16
Participants
Start Date
April 29, 2024
Primary Completion Date
May 1, 2025
Study Completion Date
May 1, 2025
Sodium zirconium cyclosilicate
In the case of hyperkalemia patients will be treated with Sodium zirconium cyclosilicate to allow the continuation of potassium enriched diet. In case hyperkalemia arises in the control group, patients will be treated with Sodium zirconium cyclosilicate as well.
RECRUITING
Leiden University Medical Center, Leiden
Collaborators (1)
AstraZeneca
INDUSTRY
Leiden University Medical Center
OTHER